List of SBIR/STTR awards granted to Zata Pharmaceuticals
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Zata Pharmaceuticals in September, 2021 for $717,598.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL158291-01 | Phase I | 717,598 | September 20, 2021 | |||||||
A SBIR Phase I contract was awarded to Zata Pharmaceuticals in March, 2019 for $780,492.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HL145783-01 | Phase I | 780,492 | March 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Zata Pharmaceuticals in September, 2018 for $402,225.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM130187-01 | Phase I | 402,225 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Zata Pharmaceuticals in March, 2020 for $1,010,910.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44HL145783-02 | Phase II | 1,010,910 | March 15, 2020 | |||||||
A SBIR Phase I contract was awarded to Zata Pharmaceuticals in September, 2015 for $402,588.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL125015-01A1 | Phase I | 402,588 | September 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Zata Pharmaceuticals in June, 2016 for $1,384,352.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM109517-02 | Phase II | 1,384,352 | June 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Zata Pharmaceuticals for $363,842.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM109517-01A1 | Phase I | 363,842 |
